Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
CSF tau/Aβ 42 ratio for increased risk of mild cognitive impairment
2007
K+ Efflux Agonists Induce NLRP3 Inflammasome Activation Independently of Ca2+ Signaling
2015
Roles of tau protein in health and disease
2017
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Hydrogen peroxide sensing, signaling and regulation of transcription factors
2014
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
2018
The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
2016
Role of Serine/Threonine Protein Phosphatase in Alzheimer’s Disease
2002
Oxidative stress, aging, and diseases
2018 Standout
The Role of NMDA Receptors in Alzheimer’s Disease
2019
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein
2003
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment
2013
CSF biomarkers for mild cognitive impairment
2004
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Mechanism and Regulation of NLRP3 Inflammasome Activation
2016 Standout
Nerves, H2O2 and Shh: Three players in the game of regeneration
2017
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
2004
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
2020
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
CSF markers for incipient Alzheimer's disease
2003
Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients
2002
Pyrrolidinyl‐Spirooxindole Natural Products as Inspirations for the Development of Potential Therapeutic Agents
2007 Standout
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
2014
Melatonin modulates cytoskeletal organization in the rat brain hippocampus
2012
Anomalously phosphorylated tau and Aβ fragments in the CSF correlates with cognitive impairment in MCI subjects
2005
Tau in physiology and pathology
2015 Standout
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
2013 Standout
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease
2006 Standout
Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony
2017
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
2016
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Microtubule-associated protein tau in development, degeneration and protection of neurons
2008
Neurochemical Aftermath of Amateur Boxing
2006
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers
2005
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures
2011
Alzheimer's disease
2006 Standout
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
2011
Activation of Glycogen Synthase Kinase-3β Is Required for Hyperdopamine and D2Receptor-Mediated Inhibition of Synaptic NMDA Receptor Function in the Rat Prefrontal Cortex
2009
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
Antiinflammatory Activity of Melatonin in Central Nervous System
2010
Oxidative Stress in Cancer
2020 Standout
Post-translational modifications of tau protein in Alzheimer’s disease
2004
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Coenzyme Q10 Attenuates β-Amyloid Pathology in the Aged Transgenic Mice with Alzheimer Presenilin 1 Mutation
2008
Procyanidins and Alzheimer’s Disease
2019
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation
2019
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
2004
Multiple Defects in Energy Metabolism in Alzheimers Disease
2010
AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
2011
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease
2004
The Role of Biomarkers in Clinical Trials for Alzheimer Disease
2006
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
No neurochemical evidence for brain injury caused by heading in soccer
2007
Synthesis and Structure–activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH Receptor
2003
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Melatonin reduces the impairment of axonal transport and axonopathy induced by calyculin A
2011
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
2009 Standout
Precision Redox: The Key for Antioxidant Pharmacology
2020
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Assessing mitochondrial dysfunction in cells
2011 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
Hydrogen Peroxide and Redox Regulation of Developments
2018
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation
2013
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a Potent and Orally Active Antagonist of the Human Gonadotropin-Releasing Hormone Receptor. Design, Synthesis, and in Vitro and in Vivo Characterization
2005
Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
2012
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
2008
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
2020
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Comprehensive Survey of Combinatorial Library Synthesis: 2004
2005
Melatonin reduces neuronal loss and cytoskeletal deterioration: implications for Psychiatry
2009
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Xiaochuan Wang being referenced
Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling
2016
Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation
2016
Synaptic Released Zinc Promotes Tau Hyperphosphorylation by Inhibition of Protein Phosphatase 2A (PP2A)
2012
Cleavage of GSK ‐3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK ‐3β activity induced by H2O2
2013
Reactive oxygen species generated from skeletal muscles are required for gecko tail regeneration
2016
Levels of Nonphosphorylated and Phosphorylated Tau in Cerebrospinal Fluid of Alzheimer's Disease Patients
2002
A novel synthesis of 7-aryl-8-fluoro-pyrrolo[1,2-a]pyrimid-4-ones as potent, stable GnRH receptor antagonists
2002
Activation of Glycogen Synthase Kinase-3 Inhibits Long-Term Potentiation with Synapse-Associated Impairments
2007
Inhibition of protein phosphatases induces transport deficits and axonopathy
2007
Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms
2005
Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
2015
Constant Illumination Induces Alzheimer-Like Damages with Endoplasmic Reticulum Involvement and the Protection of Melatonin
2009
Tau acetylates and stabilizes β‐catenin thereby promoting cell survival
2020
A Screening Library for Peptide Activated G-Protein Coupled Receptors. 1. The Test Set
2004
SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination
2014
Antioxidant Therapies for Alzheimer's Disease
2012
Prevention of isoproterenol-induced tau hyperphosphorylation by melatonin in the rat.
2005
[Alteration of beta-amyloid and glutamate transporter in the brain of diabetes rats and the underlying mechanism].
2005